Feed/Investors/Shionogi & Co

Shionogi & Co

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-10-04

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$2.5M

across 1 round

LATEST ROUND

Series B ext. · $2.5M · 2026-10-04

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Shionogi & Co: 1 round · Fireround

Company	Round	Amount	Announced	Role
Celaid Therapeutics Inc. A biotechnology startup originating from the University of Tokyo and the University of Tsukuba, with proprietary technology for the selective ex vivo expansion of hematopoietic stem cells (HSCs)	Series B ext. Verified against 4 of 8 sources	$2.5M	2026-10-04	[ PART ]